Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab182801-100μg
|
100μg |
10
|
$19.90
|
|
|
Ab182801-1mg
|
1mg |
4
|
$99.90
|
|
|
Ab182801-5mg
|
5mg |
1
|
$239.90
|
|
|
Ab182801-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$389.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Toripalimab (anti-PD-1) - Primary antibody, specific to PDCD1, Human IgG1, ANTAGONIST of Programmed cell death protein 1 antagonist |
|---|---|
| Synonyms | CD279 antibody | CD279 antigen antibody | hPD 1 antibody | hPD l antibody | hPD-1 antibody | hSLE1 antibody | PD 1 antibody | PD-1 antibody | PD1 antibody | PDCD 1 antibody | PDCD1_HUMAN antibody | PDCD1 antibody | Programmed cell death 1 antibody | Progr |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | PDCD1 |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | ANTAGONIST |
| Mechanism of action | ANTAGONIST of Programmed cell death protein 1 antagonist |
| Product Description |
Toripalimab (anti-PD-1) is the first domestic anti-tumor PD-1 antibody in China. Toripalimab (anti-PD-1) is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab (anti-PD-1) is able to bind to PD-1 and block the interaction with its ligands. Toripalimab (anti-PD-1) has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma. |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 27.1 kDa (Light Chain) & 52.1 kDa (Heavy Chain), under reducing conditions; 212.6 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 1924598-82-2 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Toripalimab (anti-PD-1) (Ab182801) - Flow Cytometry
Flow Cytometry analysis of unstimulated (left) or 500 ng/mL Ionomycin (I139530) and 10 ng/mL PMA (P408905) co-stimulated (right) Jurkat cells (24h) labelling PD-1 (red) with Toripalimab (anti-PD-1) (Ab182801) at 0.1 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Toripalimab (anti-PD-1) (Ab182801) - Flow Cytometry
Flow Cytometry analysis of unstimulated (left) or 500 ng/mL Ionomycin (I139530) and 10 ng/mL PMA (P408905) co-stimulated (right) MOLT-4 cells (24h) labelling PD-1 (red) with Toripalimab (anti-PD-1) (Ab182801) at 0.1 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Toripalimab (anti-PD-1) (Ab182801) - ELISA
Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Toripalimab (anti-PD-1) (Ab182801) with the EC50 of 14.20 ng/mL.
Toripalimab (anti-PD-1) (Ab182801) - SEC
The purity of Toripalimab (anti-PD-1) (Ab182801) is more than 95% verified by HPLC.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | May 15, 2024 | Ab182801 | |
| Certificate of Analysis | May 15, 2024 | Ab182801 | |
| Certificate of Analysis | May 15, 2024 | Ab182801 |
Starting at $109.90
Starting at $69.90
Starting at $89.90
Starting at $109.90
Starting at $89.90
Starting at $59.90
Starting at $59.90
Starting at $69.90
Starting at $89.90
Starting at $49.90
Starting at $69.90
Starting at $109.90
Starting at $29.90
Starting at $109.90
Starting at $109.90
Starting at $109.90